[
    "{\"step_by_step_thinking\": \"First, I need to understand what CPX-351 is. CPX-351 is a liposomal formulation of cytarabine and daunorubicin, two drugs used in the treatment of leukemia. Next, I need to check if it has been approved by the FDA and the EMA. The FDA (Food and Drug Administration) is the health regulatory body in the United States, while the EMA (European Medicines Agency) is the health regulatory body in the European Union. After researching, I found that CPX-351 has been approved by both the FDA and the EMA for the treatment of certain types of leukemia.\", \"answer_choice\": \"A\"}"
]